BioNotebook: Three clinical trial updates and two research deals
This article was originally published in Scrip
Executive Summary
Recro Pharma sinks on pain drug update; Ultragenyx plans Phase III study after I/II success; Tetraphase advances eravacycline into pivotal trial; Soligenix readies acquired therapy for Phase III; and EMD Serono initiates lupus collaboration.